| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 7% | $1,642,800 | 4,440,000 | BVF PARTNERS L P/IL | 31 Mar 2025 | |||
| TANG CAPITAL MANAGEMENT LLC | 5% | -49.9% | $1,183,700 | -$1,112,990 | 3,115,000 | -48.5% | TANG CAPITAL MANAGEMENT, LLC | 30 Jun 2025 |
| VANGUARD GROUP INC | 4.41% | $965,717 | 2,610,045 | The Vanguard Group | 31 Dec 2024 | |||
| GOLDMAN SACHS GROUP INC | 2.8% | $622,842 | 1,683,356 | THE GOLDMAN SACHS GROUP, INC. | 31 Dec 2024 | |||
| BlackRock, Inc. | 0.6% | -96% | $135,478 | -$1,025,726 | 369,048 | -88.3% | BlackRock, Inc. | 30 Jun 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 2,000 | $720 | -$10,839,974 | $0.36 | 1 |
| 2025 Q2 | 29,539,370 | $10,842,560 | -$793,553 | $0.3671 | 62 |
| 2025 Q1 | 33,845,637 | $8,763,416 | -$4,443,040 | $0.2591 | 70 |
| 2024 Q4 | 39,972,031 | $22,485,572 | -$3,751,363 | $0.5626 | 70 |
| 2024 Q3 | 45,935,957 | $27,556,513 | -$42,322,821 | $0.5999 | 67 |
| 2024 Q2 | 52,117,516 | $140,353,793 | +$17,122,980 | $2.7 | 79 |
| 2024 Q1 | 43,980,695 | $225,620,623 | +$110,373,555 | $5.13 | 61 |
| 2023 Q4 | 25,848,863 | $13,880,951 | -$1,444,451 | $0.537 | 31 |
| 2023 Q3 | 28,047,314 | $18,583,583 | -$5,577,531 | $0.6626 | 40 |
| 2023 Q2 | 31,537,990 | $48,818,036 | +$22,972,167 | $1.52 | 38 |
| 2023 Q1 | 16,241,361 | $30,858,572 | +$3,765,785 | $1.9 | 27 |
| 2022 Q4 | 14,423,778 | $13,696,323 | +$91,721 | $0.95 | 26 |
| 2022 Q3 | 14,278,557 | $16,134,000 | -$1,527,236 | $1.13 | 21 |
| 2022 Q2 | 15,368,572 | $21,517,000 | -$7,037,226 | $1.4 | 24 |
| 2022 Q1 | 18,712,566 | $47,158,000 | +$631,515 | $2.52 | 28 |
| 2021 Q4 | 15,932,443 | $95,906,000 | -$3,116,582 | $6.02 | 33 |
| 2021 Q3 | 15,882,998 | $123,294,000 | -$8,545,986 | $7.79 | 21 |
| 2021 Q2 | 16,192,115 | $217,244,000 | +$217,244,000 | $13.57 | 35 |